04/02/2023
Laboratoriumgeneeskunde
Alternative genetic alterations of MYC, BCL2, and/or BCL6 in high-grade B-cell lymphoma (HGBL) and diffuse large B-cell lymphoma (DLBCL): Can we identify different prognostic subgroups?
Genes Chromosomes Cancer. 2023;1–8 - PMID: 37897298dr. Devos Helenadr. Snauwaert Sylviadr. De Paepe Pascaledr. Emmerechts Jandr. Cauwelier Barbara
04/02/2023
Laboratoriumgeneeskunde
Germline heterozygous SH2B3-mutations and (idiopathic) erythrocytosis: detection of a previously undescribed mutation.
eJHaem 2023;1-5 - https://doi.org/10.1002/jha2.800dr. Devos Helena
04/02/2023
Laboratoriumgeneeskunde
Bias reduction improves accuracy and informativity of high-throughput sequencing chimerism assays.
Clin Chim Acta. 2023 Jul 1:547:117452 - PMID: 37343694dr. Devos Helenadr. sc. Nollet Friedel
04/02/2023
Laboratoriumgeneeskunde
Breast Implant associated EBV-positive Diffuse Large B-cell Lymphoma: An underrecognized entity?
Diagn Pathol. 2023;18:52. - PMID: 37098615dr. Gieraerts Katriendr. Devos Helenadr. Snauwaert Sylviadr. De Paepe Pascaledr. Vanwalleghem Lievedr. Lesaffer Jan
01/01/2023
Laboratoriumgeneeskunde
De kunst van het kijken: rhabdomyosarcoom.
Nederlands Tijdschrift voor Hematologie 2023dr. Devos Helenadr. De Paepe Pascaledr. Emmerechts Jandr. Cauwelier Barbara
28/10/2023
Laboratoriumgeneeskunde
Alternative genetic alterations of MYC , BCL2 and/or BCL6 in high grade B-cell lymphoma (HGBL) and diffuse large B-cell lymphoma (DLBCL): can we identify different prognostic subgroups?
Genes, Chromosomes and Cancer. 2023 Oct 28. doi: 10.1002/gcc.23211. dr. Devos Helenadr. Snauwaert Sylviadr. De Paepe Pascaledr. Emmerechts Jandr. Cauwelier Barbara
25/04/2023
Anatomopathologie
Breast implant associated EBV-positive Diffuse Large B-cell lymphoma: an underrecognized entity?
Diagn Pathol. 2023 Apr 25;18(1):52. doi: 10.1186/s13000-023-01337-5.PMID: 37098615 Free PMC article. https://pubmed.ncbi.nlm.nih.gov/37098615/dr. Gieraerts Katriendr. Devos Helenadr. Snauwaert Sylviadr. Vanwalleghem Lievedr. Lesaffer Jan
28/10/2023
Hematologie
Alternative genetic alterations of MYC, BCL2, and/or BCL6 in high-grade B-cell lymphoma (HGBL) and diffuse large B-cell lymphoma (DLBCL): Can we identify different prognostic subgroups?
Genes Chromosomes Cancer. 2023 Oct 28. doi: 10.1002/gcc.23211. Online ahead of print. PMID: 37897298 dr. Devos Helenadr. Snauwaert Sylviadr. De Paepe Pascaledr. Emmerechts Jandr. Cauwelier Barbara
25/04/2023
Hematologie
Breast implant associated EBV-positive Diffuse Large B-cell lymphoma: an underrecognized entity?
Diagn Pathol. 2023 Apr 25;18(1):52. doi: 10.1186/s13000-023-01337-5. PMID: 37098615 Free PMC article. dr. Gieraerts Katriendr. Devos Helenadr. Snauwaert Sylviadr. De Paepe Pascaledr. Vanwalleghem Lievedr. Lesaffer Jan
28/10/2023
Anatomopathologie
Alternative genetic alterations of MYC, BCL2, and/or BCL6 in high-grade B-cell lymphoma (HGBL) and diffuse large B-cell lymphoma (DLBCL): Can we identify different prognostic subgroups?
Genes Chromosomes Cancer. 2023 Oct 28. doi: 10.1002/gcc.23211. Online ahead of print.PMID: 37897298dr. Devos Helenadr. Snauwaert Sylviadr. De Paepe Pascaledr. Emmerechts Jandr. Cauwelier Barbara
06/03/2022
Laboratoriumgeneeskunde
Chimerism monitoring using biallelic single nucleotide or insertion/deletion polymorphisms: how many markers to screen?
Clinica Chimica Acta 3 June 2022dr. Devos Helenadr. sc. Nollet Friedel
08/01/2022
Laboratoriumgeneeskunde
Thouverin et al. PRECISION, the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment.
ESMO Open 2022 Aug:7(4):100524dr. Devos Helena
05/01/2022
Laboratoriumgeneeskunde
Routine noninvasive prenatal screening for fetal rhesus D in maternal plasma – a two year experience from a single center in Belgium.
Transfusion 2022 May;62(5):1103-1109 PMID: 35352833dr. Devos Helenadr. Emmerechts Jandr. sc. Nollet Friedel
09/09/2021
Laboratoriumgeneeskunde
Performance assessment of the Devyser high-throughput sequencing based assay for chimerism monitoring in patients after allogeneic hematopoietic stem cell transplantation.
The Journal of Molecular Diagnostics Volume 23, Issue 9, September 2021, Pages 1116-1126dr. Devos Helenadr. sc. Nollet Friedel
01/01/2021
Laboratoriumgeneeskunde
Uw diagnose?
Ned Tijdschr hematol 2021;18:93-5.dr. Devos Helenadr. Tajdar Mercedehdr. Emmerechts Jan
02/01/2021
Laboratoriumgeneeskunde
Efficacy of ruxolitinib in B-lymphoblastic leukaemia with PCM1-JAK2 fusion gene.
Br J Haematol. 2021 Feb;192(4):e112-e115. doi: 10.1111/bjh.17340. Epub 2021 Jan 27dr. Devos Helenadr. Selleslag Dominik
01/01/2019
Laboratoriumgeneeskunde
Evaluation of Next Generation Sequencing based clonality analysis of T-cell receptor gamma gene rearrangements based on a new interpretation algorithm.
International Journal of Laboratory Hematology 2019;41(2):242-249.dr. Devos Helenadr. Emmerechts Jandr. sc. Nollet Friedel
01/01/2019
Laboratoriumgeneeskunde
Targeted next generation DNA sequencing for the detection of clonal haematopoiesis in idiopathic cytopaenia of undetermined significance (ICUS).
Belgian Journal of Hematology 2019;10:231-40dr. Devos Helenadr. Emmerechts Jandr. Selleslag Dominikdr. sc. Nollet Friedel
01/01/2019
Laboratoriumgeneeskunde
Spuriously high MCV in a patient with diabetic ketoacidosis.
Belgian Journal of Hematology 2019;10:250-4dr. Devos Helenadr. Van Erum Suzy
06/12/2023
Laboratoriumgeneeskunde
Malignant progressionof Donor-engrafted Clonal hematopoiesis in sibling recipients after stem cell transplantation.
Blood Advances, Volume 4, Issue 22dr. Devos Helena
01/01/2019
Laboratoriumgeneeskunde
Evaluation of Next Generation Sequencing based clonality analysis of T-cell receptor gamma gene rearrangements based on a new interpretation algorithm.
International Journal of Laboratory Hematology 2019;41(2):242-249.dr. Devos Helenadr. Emmerechts Jandr. sc. Nollet Friedel
01/01/2019
Laboratoriumgeneeskunde
Targeted next generation DNA sequencing for the detection of clonal haematopoiesis in idiopathic cytopaenia of undetermined significance (ICUS).
Belgian Journal of Hematology 2019;10:231-40dr. Devos Helenadr. Emmerechts Jandr. Selleslag Dominikdr. sc. Nollet Friedel
01/01/2019
Laboratoriumgeneeskunde
Spuriously high MCV in a patient with diabetic ketoacidosis.
Belgian Journal of Hematology 2019;10:250-4dr. Devos Helenadr. Tajdar Mercedehdr. Van Erum Suzydr. Emmerechts Jan
01/01/2019
Laboratoriumgeneeskunde
Diagnostic testing in myeloid malignancies by next-generation sequencing: recommendations from the Commission Personalised Medicine.
BELG J HAEMATOL 2019;10(6):241-9dr. Devos Helena
01/01/2019
Laboratoriumgeneeskunde
Targeted next generation DNA sequencing for the detection of clonal haematopoiesis in idiopathic cytopaenia of undetermined significance (ICUS).
BELG J HAEMATOL 2019;10(6):231-40dr. Devos Helenadr. Emmerechts Jandr. Selleslag Dominikdr. sc. Nollet Friedel
01/01/2018
Laboratoriumgeneeskunde
Evaluation of four hemoglobin separation analyzers for hemoglobinopathy diagnosis.
J Clin Lab Anal. 2018;32:e22224.dr. Devos Helenadr. Emmerechts Jandr. Langlois Michel
01/01/2018
Laboratoriumgeneeskunde
Evaluation of Four Hemoglobin Separation Analyzers for Hemoglobinopathy Diagnosis.
Journal of Clinical Lab Analysis 2018;32(1)dr. Devos Helenadr. Emmerechts Jandr. Langlois Michel
01/01/2018
Laboratoriumgeneeskunde
Diagnostic utility of the lymphoid screening tube supplemented with CD34 for Ogata score calculation in patients with peripheral cytopenia.
Hematology 2018;24(1):166-172.dr. Devos Helenadr. Emmerechts Jan
12/08/2018
Laboratoriumgeneeskunde
Evaluation of next-generation sequencing-based clonality analysis of T-cell receptor gamma gene rearrangements based on a new interpretation algorithm.
Int J Lab Hematol. 2018 Dec 8.dr. Devos Helenadr. Emmerechts Jan
06/12/2023
Laboratoriumgeneeskunde
Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-MLLT10 Fusion.
Acta Haematol 2018;140:97–104dr. Devos Helenadr. Selleslag Dominik
12/01/2018
Laboratoriumgeneeskunde
“Diagnostic Utility of the Lymphoid Screening Tube for Ogata Score Calculation in Patients with Peripheral Cytopenia”.
Hematology. 2018 Dec;24(1):166-172.dr. Flore Katelijnedr. Devos Helenadr. Emmerechts JanLaboratoriumgeneeskunde
Themadag dialyse: Plasmaferese algemene principes.
Brugge2023-03-16dr. Devos HelenaLaboratoriumgeneeskunde
Themadag dialyse: Plasmaferese algemene principes.
Brugge2023-03-09dr. Devos HelenaLaboratoriumgeneeskunde
Post transplant monitoring: the future of chimerism testing.
Brugge2023-02-16dr. Devos Helenadr. sc. Nollet FriedelLaboratoriumgeneeskunde
Evaluation of the automated HemosIL®CL HIT-IgG chemiluminescence immunoassay on the new ACL TOP®970 coagulation analyzer
Mechelen2023-11-30dr. Devos HelenaLaboratoriumgeneeskunde
Investigation of the prevalence and clinically relevant causes of shortened aPTT in a clinical diagnostic laboratory
Mechelen2023-11-30dr. Devos HelenaLaboratoriumgeneeskunde
Undersized TRG rearrangements in five unrelated patients : to be considered as clonal markers?
Brussel2023-02-04dr. Devos HelenaLaboratoriumgeneeskunde
Diagnostic utility of the flow cytometry lymphoid screening tube supplemented with TRBC1 for the assessment of T-cell clonality and T-cell lymphoma
Brussel2023-02-04dr. Devos HelenaLaboratoriumgeneeskunde
Clinical validation of Optical Genome Mapping as a molecular diagnostics tool for acute leukemia
Brussel2023-02-04dr. Devos HelenaLaboratoriumgeneeskunde
Clinical validation of Optical Genome Mapping as a molecular diagnostics tool for acute leukemia
Brussel2023-01-23dr. Devos HelenaLaboratoriumgeneeskunde
ERIC preceptorship: realizing precision medicine in CLL: why and How
Stresa, Italy2023-11-17dr. Devos HelenaLaboratoriumgeneeskunde
LOK: Evolutie van de financiering van de klinische biologie Henk Lowagie
Brugge2023-10-16dr. Devos HelenaLaboratoriumgeneeskunde
Opleiding veiligheid en hygiëne: Martine Sijmons
Brugge2023-10-09dr. Devos HelenaLaboratoriumgeneeskunde
SMAO-5: voordracht NGS netwerk dr. Devos en dr. Van Huysse
Brugge2023-06-05dr. Devos HelenaLaboratoriumgeneeskunde
Masterclass Management & leadership voor artsen: Brainplot nieuw Ziekenhuis ir Pascal Verdonck
Brugge2023-05-11dr. Devos HelenaLaboratoriumgeneeskunde
EFI 2023- 36th european immunogenetics & histocompatibility conference
Nantes, France2023-04-29dr. Devos HelenaLaboratoriumgeneeskunde
EFI 2023- 36th european immunogenetics & histocompatibility conference
Nantes, France2023-04-28dr. Devos HelenaLaboratoriumgeneeskunde
EFI 2023- 36th european immunogenetics & histocompatibility conference
Nantes, France2023-04-27dr. Devos HelenaLaboratoriumgeneeskunde
Masterclass Management & leadership voor artsen: ICT en het belang van ICT in de zorg Deel 2 Marc Monballieu
Brugge2023-04-20dr. Devos HelenaLaboratoriumgeneeskunde
Masterclass Management & leadership voor artsen: ICT en het belang van ICT in de zorg Deel 1 Marc Monballieu
Brugge2023-02-09dr. Devos HelenaLaboratoriumgeneeskunde
Masterclass Management & leadership voor artsen: Innovatie management deel 2 – Dr. Ir. Pascal Verdonck
Brugge2023-02-09dr. Devos HelenaLaboratoriumgeneeskunde
Masterclass Management & leadership voor artsen: Innovatie management deel 1 – Dr. Ir. Pascal Verdonck
Brugge2023-01-12dr. Devos HelenaLaboratoriumgeneeskunde
Belang van moleculaire diagnostiek bij MDS en MPN.
Brugge2022-04-28dr. Devos HelenaLaboratoriumgeneeskunde
Belang van Moleculaire Diagnostiek bij MDS en MPN.
Gent2022-02-17dr. Devos HelenaLaboratoriumgeneeskunde
Performance evaluation of routine noninvasive prenatal screening for fetal rhesus D in maternal plasma.
Brugge2022-02-05dr. Devos HelenaLaboratoriumgeneeskunde
Comparative evaluation of automated mechanical tissue dissociation for flow cytometric analysis.
dr. Devos HelenaLaboratoriumgeneeskunde
CHALLENGING DIAGNOSTIC ASSESSMENT OF GERMLINE RUNX1 VARIANTS IN MYELOID MALIGNANCIES: A CASE REPORT OF A PATIENT PRESENTING WITH A NOVEL GERMLINE RUNX1 VARIANT.
Bruggedr. Devos HelenaLaboratoriumgeneeskunde
Immunophenotypic and molecular phenotyping of cup-like morphology in AML.
Brusseldr. Devos HelenaLaboratoriumgeneeskunde
Donor cell-derived acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: molecular confirmation by next-generation sequencing.
Brusseldr. Devos HelenaLaboratoriumgeneeskunde
Early relapse detection after allogeneic stem cell transplantation by chimerism analysis based on Next Generation Sequencing of insertion/deletion polymorphisms.
Glasgow UKdr. Devos HelenaLaboratoriumgeneeskunde
Plaats van mutatieanalyse bij donorselectie: 2 voorbeelden.
Drongendr. Devos HelenaLaboratoriumgeneeskunde
Droplet Digital PCR Phasing (DROP-PHASE): A Novel Method for Straightforward Detection of BCR-ABL1 Compound Mutations in Tyrosine Kinase Inhibitors Resistant Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL).
Orlandodr. Devos HelenaLaboratoriumgeneeskunde
LOK: Rol van NGS in de diagnostiek en prognose van MDS.
Bruggedr. Devos HelenaLaboratoriumgeneeskunde